Literature DB >> 3925627

The Omenn's syndrome: histological, immunohistochemical and ultrastructural evidence for a partial T cell deficiency evolving in an abnormal proliferation of T lymphocytes and S-100 +/T-6 + Langerhans-like cells.

L P Ruco, A Stoppacciaro, F Pezzella, M Mirolo, S Uccini, P Barsotti, A M Cassano, A L Boner, L Businco, A Di Fazio.   

Abstract

A 7 month old female infant was affected by a rapidly fatal familial disease highly reminiscent of Omenn's syndrome. She presented with widespread eczematous lesions, hepatosplenomegaly, superficial lymphadenopathy, peripheral blood lymphocytosis, eosinophilia and hyper-IgE. An axillary lymph node was involved by a marked proliferation of T-3 +/T-10-- lymphocytes admixed with S-100+/T-6+/Leu-3a+/Ia + reticular cells which lacked typical LC granules; cell suspension study revealed that 90%-96% of the lymph node cells were T-11+/T-3+ lymphocytes characterized by low expression of Leu-3a and T-8 antigens and by high expression of Ia antigens (52%). Peripheral blood T lymphocytes exhibited a similar distribution of surface phenotypes. The patient died of interstitial pneumonia and an autopsy was performed. The thymus was markedly atrophic and completely devoid of lymphocytes. The peri-arteriolar lymphoid sheets of the spleen were poorly developed and were mainly composed of T-8+ lymphocytes. The mediastinal nodes were rudimentary and were populated by T-3+/T-10+ lymphocytes with low expression of Leu-3a and T-8 antigens. Our results raise the possibility that Omenn's syndrome is a peculiar primary immunodeficiency in which, despite early thymic involution, some abnormal T lymphocytes still develop in the peripheral lymphoid organs. Antigenic triggering of these cells might result in prominent proliferations of T lymphocytes and Langerhans-like cells which lead to the clinical manifestation of the disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925627     DOI: 10.1007/bf00701330

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  22 in total

1.  Ia antigen expression on human epidermal Langerhans cells.

Authors:  G Rowden; M G Lewis; A K Sullivan
Journal:  Nature       Date:  1977-07-21       Impact factor: 49.962

2.  Rapidly fatal familial histiocytosis associated with eosinophilia and primary immunological deficiency.

Authors:  R F Barth; G G Vergara; S K Khurana; J T Lowman; J B Beckwith
Journal:  Lancet       Date:  1972-09-09       Impact factor: 79.321

3.  The paracortical area in dermatopathic lymphadenitis and other reactive conditions of the lymph node.

Authors:  J J van der Oord; C de Wolf-Peeters; R de Vos; V J Desmet
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1984

4.  Use of monoclonal antibodies in a study of the development of T lymphocytes in the human fetus.

Authors:  G E Asma; R L Van den Bergh; J M Vossen
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

5.  Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems.

Authors:  G S Wood; R Warnke
Journal:  J Histochem Cytochem       Date:  1981-10       Impact factor: 2.479

6.  Reactivity of Langerhans cells with hybridoma antibody.

Authors:  E Fithian; P Kung; G Goldstein; M Rubenfeld; C Fenoglio; R Edelson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

7.  Microtubules of systemic lupus erythematosus.

Authors:  F Györkey; J G Sinkovics
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

8.  Combined immunodeficiency and reticuloendotheliosis with eosinophilia.

Authors:  H D Ochs; S D Davis; E Mickelson; K G Lerner; R J Wedgwood
Journal:  J Pediatr       Date:  1974-10       Impact factor: 4.406

9.  Persistent lymphadenopathy in homosexual men: a clinical and ultrastructural study.

Authors:  M G Anderson; J Dixey; P Key; D S Ellis; G Tovey; T F McCaul; I M Murray-Lyon; B Gazzard; A Lawrence; B Evans
Journal:  Lancet       Date:  1984-04-21       Impact factor: 79.321

10.  Severe combined immunodeficiency disease: a pathological analysis of 26 cases.

Authors:  S Gosseye; N Diebold; C Griscelli; C Nezelof
Journal:  Clin Immunol Immunopathol       Date:  1983-10
View more
  5 in total

1.  Restricted heterogeneity of T lymphocytes in combined immunodeficiency with hypereosinophilia (Omenn's syndrome).

Authors:  G de Saint-Basile; F Le Deist; J P de Villartay; N Cerf-Bensussan; O Journet; N Brousse; C Griscelli; A Fischer
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

2.  Selective gamma-chain T-cell receptor gene rearrangements in a patient with Omenn's syndrome: absence of V-II subgroup (V gamma 9) transcripts.

Authors:  G Mathioudakis; R A Good; Y Chernajovsky; N K Day; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

3.  Oligoclonal expansion of CD45RO+ T lymphocytes in Omenn syndrome.

Authors:  T O Harville; D M Adams; T A Howard; R E Ware
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

4.  Characterization of immune function and analysis of RAG gene mutations in Omenn syndrome and related disorders.

Authors:  T Wada; K Takei; M Kudo; S Shimura; Y Kasahara; S Koizumi; K Kawa-Ha; Y Ishida; S Imashuku; H Seki; A Yachie
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

Review 5.  Lymph node pathology in primary combined immunodeficiency diseases.

Authors:  F Facchetti; L Blanzuoli; M Ungari; O Alebardi; W Vermi
Journal:  Springer Semin Immunopathol       Date:  1998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.